Additional information
| Active substance | Temozolomide |
|---|---|
| Water Retention | No significant impact |
| Hepatotoxicity | Low |
| Lab Test | CBC (Complete Blood Count) monitoring |
| Strength | 100mg |
| Also known as | TMZ, Methazolastone |
| Blood pressure | No direct effect |
| Trade name | Temodar, Temodal, Temcad |
| Storage conditions | Store at controlled room temperature, 20-25В°C (68-77В°F) |
| Chemical name | 3,4-Dihydro-3-methyl-4-oxoimidazo[5,1-d]-1,2,3,5-tetrazine-8-carboxamide |
| Formula | C6H6N6O2 |
| Substance class | Alkylating agent |
| Main action | Antineoplastic |
| Half-life | 1.8 hours |
| Dosage (medical) | Typically 150-200 mg/mВІ per day for 5 days every 28 days cycle |
| Dosage (sports) | Not applicable |
| Effects | Antitumor effect, crosses the blood-brain barrier |
| Side effects | Nausea, vomiting, constipation, loss of appetite, alopecia, headache, fatigue, neutropenia, thrombocytopenia |
| Use in sports | None |
| Manufacturer | Cipla Ltd. |
| Packing | 5 caps/bottle |
Prograf 5mg Astellas Pharma
Champix Starter Pack Pfizer
Fostimon (Merional) 75 (HMG) IBSA
Balkan Pharma Halotestin 10mg 100 Tabletten
Norvacs 10 mg Pfizer
FUCIDIN 500 mg Abdi Ibragim
Seretide Disckus (Advair) 250 mcg Glaxosmithkline 

Reviews
There are no reviews yet.